Myosteatosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Myosteatosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

RecruitingNot Applicable

NCT07373834

Tirzepatide and Muscle Outcomes in Obesity

This study is evaluating whether a dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, tirzepatide, ca…

Slovenia30 participantsStarted 2026-01

Treatment: Tirzepatide, Placebo

RecruitingNot Applicable

NCT06631820

The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD

Some foods have components that can prevent and treat some diseases and provide beneficial effects for health. These components naturally occurring in foods are…

Sweden10 participantsStarted 2025-01-17

Treatment: Epicatechin extract

RecruitingNot Applicable

NCT05525039

RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myosteatosis and NMJ Degeneration

The investigators' pre-clinical study confirms the positive effects of combined treatment (VT + HMB) on reducing fat-to-lean tissue ratio, intramuscular fat inf…

Hong Kong200 participantsStarted 2023-01-12

Treatment: Low-magnitude High-frequency Vibration, β-hydroxy β-methylbutyrate (HMB) supplement

RecruitingNot Applicable

NCT06419244

Myosteatosis in Oeso-gastric Cancer: Clinical Impacts

The aim of this project is to study the presence of cancer-associated adipocytes in oesogastric cancers and their possible links with myosteatosis. This researc…

Belgium50 participantsStarted 2024-05-01

Treatment: Myosteatosis

All recent trials (23 shown)

CompletedNot Applicable

NCT04807803

Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension

Minimal hepatic encephalopathy (MHE) is a subclinical cognitive impairment and represents the mildest type of hepatic encephalopathy (HE). Portal hypertension i…

France82 participantsStarted 2021-03-26

Treatment: Assessment of Minimal hepatic encephalopathy (MHE)

CompletedPhase 2

NCT07466758

Personalized Pharmaconutrition Therapy for Myosteatosis, Sarcopenia, and Prognosis in Gastric Cancer Patients

This randomized controlled trial aims to evaluate the effect of personalized pharmaconutrition therapy on myosteatosis, sarcopenia, and disease prognosis in pat…

Turkey (Türkiye)40 participantsStarted 2024-10-16

Treatment: Pharmaconutrition

Myosteatosis

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Tirzepatide and Muscle Outcomes in Obesity

The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD

RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myosteatosis and NMJ Degeneration

Myosteatosis in Oeso-gastric Cancer: Clinical Impacts

All recent trials (23 shown)

Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension

Personalized Pharmaconutrition Therapy for Myosteatosis, Sarcopenia, and Prognosis in Gastric Cancer Patients

Trial phase breakdown

Trial status

Actively recruiting — 4 trials

Tirzepatide and Muscle Outcomes in Obesity

The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD

RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myosteatosis and NMJ Degeneration

Myosteatosis in Oeso-gastric Cancer: Clinical Impacts

All recent trials (23 shown)

Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension

Personalized Pharmaconutrition Therapy for Myosteatosis, Sarcopenia, and Prognosis in Gastric Cancer Patients

CT Body Composition as Predictor of Exercise Therapy Outcome in Peripheral Arterial Disease

Sarcopenia and NMIBC Prognosis Study

Evaluating the Impact of Psoas Muscle Size, Composition, and Clinical Frailty on Long-term Outcomes Following Elective E…

Influence of Nutritional Status on Oncologic and Operative Outcome in Patients Operated for Retroperitoneal Sarcoma

Protocol for Muscle Attenuation Cut-offs in Cirrhosis

Building of Prognosis Model for Patients With Cirrhosis Based on Sarcopenia Assessed by Deep Learning

Investigating Myosteatosis in Steatotic Liver Diseases

Targeting the Skeletal Muscle to Treat Metabolic Dysfunction-associated Steatotic Liver Disease

Detection and Treatment of Sarcopenia and Myosteatosis in Older African Americans

Prognostic Value of Myosteatosis and Creatinine-to-cystatin C Ratio in Patients With Pancreatic Ductal Adenocarcinoma

A Cross Sectional Study for Determining Prevalence of Sarcopenia and Myosteatosis in Cirrhotic Patients and to Study the…

Body Composition Manipulation in CoLorectal cancEr (BiCyCLE): Neuromuscular Electrical Stimulation (NMES)

Muscle Multi-parametric NMR Imaging Development in Aged People With Sarcopenia or Frailty Syndrome; CLINical Study

The Relationship Betweensarcopenia And Myosteatosis With The Natural History Of Liver Cirrhosis

Muscle in Acromegaly and Cushing's Syndrome

Mitochondrial Activity and Myosteatosis in the Cachexia of Cancers of the Upper Aerodigestive Tract

ERAS in Colorectal Surgery Diminishes the Negative Impact of Sarcopenia on Short Term Outcomes